Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma-Reference-Cited by-同舟云学术

Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma

Published:2016-04-16 Issue:2 Volume:104 Page:236-244
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Makita Shinichi,Maruyama Dai,Maeshima Akiko Miyagi,Taniguchi Hirokazu,Miyamoto Ken-ichi,Kitahara Hideaki,Fukuhara Suguru,Munakata Wataru,Kobayashi Yukio,Itami Jun,Tobinai Kensei

Funder

National Cancer Center Research and Development Fund

Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research

a grant for cancer research (Practical Research for Innovative Cancer Control) from the Japan Agency for Medical Research and Development (AMED)

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-016-2007-1.pdf

Reference38 articles.

1. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107:265–76.

2. Connors JM. State-of-the-art therapeutics: hodgkin’s lymphoma. J Clin Oncol. 2005;23:6400–8.

3. Devita VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med. 1970;73:881–95.

4. Longo DL, Young RC, Wesley M, Hubbard SM, Duffey PL, Jaffe ES, et al. Twenty years of MOPP therapy for Hodgkin’s disease. J Clin Oncol. 1986;4:1295–306.

5. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21:601–5.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topological importance of CD8 + T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma;2024-06-10

2. Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma;Journal of Clinical and Experimental Hematopathology;2024

3. Pathological Progress in Bone Marrow Involvement by Lymphoma;Advances in Clinical Medicine;2023

4. CD20 expression is closely associated with Epstein–Barr virus infection and an inferior survival in nodular sclerosis classical Hodgkin lymphoma;Frontiers in Oncology;2022-09-06

5. An Update on the Pathology and Molecular Features of Hodgkin Lymphoma;Cancers;2022-05-26